Trial intelligence / Profile preview

Thalidomide Preoperative Treatment for Locally Advanced Prostate Cancer

NCT00038181Phase 2Completed

Sponsor
University of Texas MD Anderson Cancer Center
Start
Oct 2000
Primary completion
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of thalidomide in prostate cancer (PCa), sponsored by University of Texas MD Anderson Cancer Center. Started Oct 2000; status: completed.

02

Drugs

thalidomide
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00038181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00038181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call